Circulating tumor DNA in HER2 amplified breast cancer: a translational research substudy of the NeoALTTO phase 3 trial.
Authors
Ignatiadis, MSilva, M
Campbell, C
Bradbury, I
de Azambuja, E
Maetens, M
Fumagalli, D
Rodrik-Outmezguine, V
Di Cosimo, S
Rosa, D
Chia, S
Wardley, Andrew M
Ueno, T
Janni, W
Huober, J
Baselga, J
Piccart, M
Sotiriou, C
Loi, S
Rothé, F
Dawson, S
Affiliation
Cancer Research Institut Jules Bordet, Université Libre de Bruxelles, Brussels, BelgiumIssue Date
2018-02-14
Metadata
Show full item recordCitation
Circulating tumor DNA in HER2 amplified breast cancer: a translational research substudy of the NeoALTTO phase 3 trial 2018, 78(4 Suppl): PD3-03 Cancer ResJournal
Cancer ResearchDOI
10.1158/1538-7445.SABCS17-PD3-03Type
Meetings and ProceedingsLanguage
enISSN
0008-54721538-7445
ae974a485f413a2113503eed53cd6c53
10.1158/1538-7445.SABCS17-PD3-03